Amylyx Pharmaceuticals
Latest round
- Series C
Last raised
- Jul 2021
Total raised
- $169M
Investors
- 15
About Amylyx Pharmaceuticals
Based in Massachusetts, US, and founded in 2013 by co-founders Joshua Cohen and Justin Klee, Amylyx Pharmaceuticals, Inc. operates as a pharmaceutical company working on developing a novel therapeutic for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. Amylyx Pharmaceuticals offers an oral drug candidate AMX0035, a combination of taurursodiol and Buphenyl, two existing compounds that have synergistic effects in preventing nerve cell death and neurotoxic inflammation in multiple preclinical models, used for the early treatment of patients suffering from Alzheimer's and other neuroinflammation diseases. The company conducted the CENTAUR trial of AMX0035 which was a randomized, double-blind, placebo-controlled Phase II clinical trial completed in late 2019. Amylyx Pharmaceuticals plans to support the clinical development and potential launch of its candidate product AMX0035, for the treatment of ALS, and further research and development in other neurodegenerative diseases.
Who invested in Amylyx Pharmaceuticals
15 investors across 3 rounds
See all investors in Amylyx Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Amylyx Pharmaceuticals
Who invested in Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Amylyx Pharmaceuticals raised?
Amylyx Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Amylyx Pharmaceuticals last raise money?
Amylyx Pharmaceuticals's most recent round on record is a Series C, in Jul 2021.
What does Amylyx Pharmaceuticals do?
Based in Massachusetts, US, and founded in 2013 by co-founders Joshua Cohen and Justin Klee, Amylyx Pharmaceuticals, Inc.
Where is Amylyx Pharmaceuticals headquartered?
Amylyx Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Amylyx Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Amylyx Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Amylyx Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.